X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Risperdal bottle Johnson & Johnson’s schizophrenia drug Risperdal at Skenderian Apothecary in Cambridge, Massachusetts, on Jan. 23, 2007. Photo: JB Reed/Bloomberg News.

The Pennsylvania Supreme Court has ruled that the start date of the statute of limitations for bringing products liability claims over antipsychotic drug Risperdal must be determined by a jury following a factual analysis in each individual case.

In identical 6-1 decisions issued Nov. 20 in Saksek v. Janssen and Winter v. Janssen, the justices overturned a Superior Court ruling that granted summary judgment to Johnson & Johnson subsidiary Janssen and tossed out lawsuits filed by plaintiffs Jonathan Saksek and Joshua Winter—and, by extension, thousands of other plaintiffs—who alleged they developed excess breast tissue as a result of taking Risperdal.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Zack Needles

Zack Needles is Global Managing Editor, Regional Brands at ALM. He is also the Managing Editor of The Legal Intelligencer, Pennsylvania Law Weekly, Delaware Business Court Insider and Delaware Law Weekly. Contact him at 215-557-2373 or [email protected] On Twitter: @ZackNeedlesTLI.

More from this author

Law Firms Mentioned

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.